Recombinant Human SEM1 Protein, N-His-SUMO & C-Strep from ProteoGenix; catalogue ARO-P10766; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human SEM1 Protein, also known as Semenogelin-1, is a protein that is encoded by the SEMG1 gene in humans. This protein is a member of the semenogelin family and is primarily found in the seminal vesicles, where it plays a crucial role in semen coagulation and sperm motility. In this article, we will explore the structure, activity, and applications of Recombinant Human SEM1 Protein.
Recombinant Human SEM1 Protein is a 306 amino acid protein with a molecular weight of approximately 34 kDa. It is composed of two major domains: a central region containing a high number of cysteine residues and a C-terminal domain rich in proline and glycine. These domains are important for the protein’s function in semen coagulation and sperm motility.
The crystal structure of Recombinant Human SEM1 Protein has been determined, revealing a dimeric structure with a central coiled-coil domain and two globular domains at the ends. This structure is essential for the protein’s ability to interact with other proteins and form a stable coagulum in semen.
The primary function of Recombinant Human SEM1 Protein is to promote semen coagulation. During ejaculation, this protein is secreted by the seminal vesicles and interacts with other proteins in semen to form a coagulum. This coagulum helps to keep the sperm in place and protect them from the acidic environment of the female reproductive tract.
In addition to its role in semen coagulation, Recombinant Human SEM1 Protein also plays a crucial role in sperm motility. It has been shown to bind to the surface of sperm cells and facilitate their movement. This activity is essential for successful fertilization and reproduction.
Recombinant Human SEM1 Protein has various applications in both research and clinical settings. One of the main uses of this protein is in the study of semen coagulation and male fertility. Researchers can use Recombinant Human SEM1 Protein to understand the mechanisms of semen coagulation and its role in male fertility.
In clinical settings, Recombinant Human SEM1 Protein has been used in diagnostic tests for male infertility. Abnormal levels of this protein in semen can indicate issues with semen coagulation and sperm motility, which can affect fertility. Additionally, Recombinant Human SEM1 Protein has also been investigated as a potential biomarker for prostate cancer.
Furthermore, Recombinant Human SEM1 Protein has potential therapeutic applications. Studies have shown that this protein can inhibit the growth of certain bacteria and viruses, making it a potential candidate for the development of new antimicrobial agents.
In summary, Recombinant Human SEM1 Protein is a crucial protein involved in semen coagulation and sperm motility. Its unique structure and activity make it an essential component of male fertility and reproductive health. With its various applications in research and clinical settings, Recombinant Human SEM1 Protein continues to be a valuable tool for understanding and treating male reproductive disorders.
ProteoGenix catalogue number ARO-P10766. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 21.77 kDa; Fragment: Ser2-Ser70; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
